Tri-Solfen registered in New Zealand for sheep and cattle husbandry procedures

Nov 16, 2017

Medical Ethics Pty Ltd (“Medical Ethics” or “the Group”), a commercial and development company focused on pain mitigation in wounds for humans and animals, announces that its wholly owned subsidiary, Animal Ethics Pty Ltd (Animal Ethics), has successfully registered Tri-Solfen in New Zealand for sheep and cattle husbandry procedures. Tri-Solfen is a local anaesthetic and antiseptic gel spray that adheres well to wounds and acts as a barrier to environmental stimuli, promotes haemostasis and improve wound healing. Tri-Solfen was registered through the Ministry for Primary Industries, which leads and facilitates the management of animal welfare policy and practice in New Zealand.   Over one billion livestock animals globally undergo highly invasive painful husbandry procedures annually. Tri-Solfen is already registered in Australia separately for sheep and cattle husbandry procedures, where it is marketed and distributed by Bayer Animal Health, a global leader in animal health. To date, Tri-Solfen has been used to successfully treat over 80 million animals undergoing routine surgeries in the Australian livestock industries.   Animal Ethics accelerated the... ...

Read More

CVO – work to be done on antimicrobial use

Nov 13, 2017

Latest UK Veterinary Antibiotic Resistance and Sales Surveillance figures show antimicrobial use in food-producing animals has decreased. UK CVO Nigel Gibbens has urged small animal practitioners to take “a hard look” at the way they prescribe antimicrobials, following the publication of the latest UK Veterinary Antibiotic Resistance and Sales Surveillance (VARSS) figures that show antimicrobial use in food-producing animals has fallen by more than 27% in the last two years – the lowest level since records began. A drop in usage from 62mg/kg in 2014 to 45mg/kg in 2016 means a Government target of 50mg/kg – set following recommendations in the 2016 O’Neill Review on antimicrobial resistance – has been hit two years ahead of schedule. While Prof Gibbens welcomed the reduction in usage of antimicrobials in the farming sector, he was quick to point out more work needed to be done, particularly in the companion and equine sector, where he said figures were “not great”. “We won’t forget we need to deal with that,” Prof Gibbens commented at the Responsible Use... ...

Read More

Campaign urges owners and vets to wise up to worms

Nov 13, 2017

A campaign to increase veterinary professional and owner knowledge about the growing threat of worms in the UK has been launched. The Wormwise campaign from Elanco, and its Milbemax product, aims to encourage owners to visit their veterinary practice to properly assess pets’ risk of worms and talk about optimal deworming frequency. Veterinary professionals are also being urged to share responsible worming messages to help owners understand the changing and growing threat tapeworm, roundworm and lungworm poses across the UK and Ireland. A series of practice materials, featuring Milly the cat and Max the dog, have been produced to help staff spread the word. Plans are also afoot to take the message to shopping centres across the UK this year, to “disgust and delight” shoppers. At the heart of the campaign is the mantra “being Wormwise is EASY”, which stands for four steps: Educate yourself about worms Assess your pets’ risk Seek advice from your vet You can take worm control to the max “Wormwise will be build over the... ...

Read More

New treatment that enhances product choice is ‘spot-on’

Nov 13, 2017

Vets have another tool in their kit to treat fleas and ticks with the release of Bravecto Spot-on for Dogs. MSD Animal Health has added to its existing range with the new product, which offers 12-week flea and tick protection, and provides vets and owners with more choice when it comes to treatment. The complementary product joins the Bravecto Dog Chew and follows swiftly on the heels of the launch of Bravecto Spot-on for Cats. MSD marketing manager Amanda Melvin said: “Our research has shown convenience is the key to improving compliance and successfully eradicating fleas and ticks. “By offering a new formulation of a 12-week treatment, Bravecto Spot-on for Dogs further increases the opportunity. It improves the choice for vets and pet owners, depending on the client’s lifestyle and type of dog.” The product also affords vets the opportunity to raise the topic of fleas and ticks with clients that have been more reluctant to use existing products, Ms Melvin added. A range of materials for practice staff and... ...

Read More

Norbrook launches product compendium

Nov 13, 2017

Norbrook Laboratories has launched the latest edition of its product compendium for vets – an easy-to-use reference guide to all of the company’s products. Douglas Palmer, veterinary advisor for Norbrook, said products are easy to find, with a choice of searching alphabetically, by species or by active ingredient – with important information, such as safety instructions, withdrawal periods, product indications and dosage rates under the name of each product. The compendium contains data sheets for recently launched products, including: Solantel – a closantel-containing oral suspension for sheep Thyronorm – a liquid oral suspension for treating hyperthyroidism in cats Betafuse – a fusidic acid/betamethasone gel for dogs A copy of the compendium can be obtained from your Norbrook territory manager, or by telephoning 01536 741147. Alternatively, a digital version can be downloaded from the Norbrook website and the datasheets are also available on the Norbrook Veterinary Excellence Tool app, available to download for Apple and Android devices. ...

Read More

Pimobendan study outcome – a ‘revolution’ for vet cardiology

Nov 13, 2017

A product that delays onset of congestive heart failure (CHF) in dogs by 15 months offers a “paradigm shift” in the way vets diagnose and treat myxomatous mitral valve disease (MMVD). Boehringer Ingelheim, the company behind pimobendan drug Vetmedin, cautiously estimated 7.5% of all dogs would suffer heart disease in their lifetimes, with MMVD its most prevalent form. Vetmedin was already licensed for the treatment of canine CHF from dilated cardiomyopathy or valvular insufficiency, as well as for treatment of cardiomyopathy in the preclinical stage in Dobermann pinschers. However, following the largest clinical trial in veterinary cardiology, the product can now be used by vets to treat the preclinical stage of MMVD, delaying onset of the clinical symptoms of heart failure. At an official launch for the European veterinary press, held in Frankfurt and attended by Veterinary Times, it was noted up to 40 million dogs worldwide could now benefit with treatment from pimobendan. The evaluation of pimobendan in dogs with cardiomegaly (EPIC) study set out to analyse whether long-term... ...

Read More

Veterinary/Animal Vaccines Market to Grow at 5.9% CAGR to 2022 Led by Europe – ReportsnReports

Nov 13, 2017

Veterinary/Animal Vaccines Market Size will reach $8.66 billion by 2022 from $6.50 billion in 2017 at a CAGR of 5.9% between (2017-2022) driven by the growth in livestock population and repeated breakouts of livestock diseases; increasing adoption of companion animals; rising incidence of zoonotic diseases; initiatives by various government agencies, animal associations, and leading players; and the introduction of new types of vaccines in the market. The key players in the veterinary vaccines market are Zoetis (US), Merck Animal Health (US), Elanco (US), Boehringer Ingelheim (Germany), Ceva (France), Phibro Animal Health (US), and Virbac (France). Other notable players operating in this market include Vetoquinol (France), Hester (India), Hipra (Spain), IDT Biologika (Germany), China Animal Husbandry (China), Biogenesis Bago (Argentina), Tianjin Ringpu (China), and Jinyu Bio-technology (China). Geographically, Europe is the largest market for veterinary vaccines market, followed by North America but the APAC region is expected to witness the highest growth in the forecast period. This growth is primarily attributed to rising pet adoption, expansion of key vaccine players in... ...

Read More

Dairy Herd Management Market Worth 3.55 Billion USD by 2022

Nov 13, 2017

According to a new market research report “Dairy Herd Management Market by Product (Automated Systems (Milking Parlours, Meters, Sensors, Reproductive & Health, Cattle Management), Software (On-premise, Cloud-based)), Application (Feeding, Breeding), End user (Large Farms) – Global Forecast to 2022“, published by MarketsandMarkets™, market is projected to reach USD 3.55 Billion by 2022 from USD 2.57 Billion in 2017, at a CAGR of 6.7%. Factors such as increasing herd size of dairy farms, increasing production and consumption of milk & dairy products, technological advancements, rising public-private funding and investments towards the development of dairy farms, and the substantial cost savings associated with dairy herd management, are driving the Dairy Herd Management Market. However, ongoing campaigns to save dairy animals from unethical herd management practices may restrain market growth to a certain extent. The milk management systems segment is estimated to account for the largest share of the automated dairy herd management systems market in 2017 On the basis of product type, the Dairy Herd Management Market is categorized into automated systems... ...

Read More

Controlled and consistent printing for veterinary practices

Nov 10, 2017

ScriptX, from UK company MeadCo, provides controlled, consistent and efficient printing from Internet Explorer. Essential for veterinary practices, ScriptX enables labels, barcodes, permission slips, claim forms, prescriptions, and more to be printed in a controlled format, from every networked Windows computer. In use across the globe, ScriptX is helping to increase efficiency and reduce costs by enabling the precise control of printing of browser-hosted content on Microsoft Windows. Veterinary practices are using ScriptX to improve procedures in several key areas: Faster, automated printing of identification details and barcoded labels to improve clinic efficiency, speeding up admissions and management of supplies Printing of vital permission and claims forms in the right format at the right location so that they can be processed accurately and rapidly Production of instant copies of animal medical records to aid diagnosis and care Creation of identification badges for staff and visitors Faster printing without the need to cancel or complete pop-up print dialogue boxes Automatic return to individual print settings as soon as a specific print... ...

Read More

Nutriad Poland 2017: Mycotoxin survey in wheat

Nov 10, 2017

Multinational feed additives producer NUTRIAD, a global leader in solutions for Mycotoxin Management solutions, concluded 2017 Nutriad Mycotoxin Survey in Poland. The survey covers 88 wheat samples from across the country and provides insight into the incidences of key mycotoxins. The 2017 mycotoxin survey concluded that the year’s harvest of wheat in Poland was of medium quality (>LOD but below EU recommendation levels) in terms of mycotoxin contamination. The results showed that 83% of the wheat samples were contaminated with DON. None of the samples contained AfB1, FB1, FB2, T-2 toxin and HT-2 toxin. Only 2,3 % of samples contained ZEN, an unexpectedly low incidence of contamination. The average concentrations of the recovered mycotoxins were low. The highest concentration of DON found in one of the samples was 3990 μg/kg. As expected, the results showed that 1,1% of wheat samples were contaminated with OTA and the highest concentration found in one sample was 2 μg/kg. The Nutriad 2017 mycotoxin survey concluded that the year’s harvest of wheat in Poland was... ...

Read More